TWiV 1243: Capitalism, COVID, and cancer
This Week in Virology
00:00
Innovations in HIV Treatment and PrEP
This chapter explores the advancements in HIV treatments, particularly focusing on lenacapivir and its promising twice-a-year administration. It reviews the outcomes of various clinical trials, highlighting success rates in overall viral suppression and the implications of combination therapies. The chapter also critically addresses the economic challenges associated with drug pricing and access, emphasizing the need for affordability in combating AIDS globally.
Transcript
Play full episode
